Assess whether integration costs were sandbagged in the CIM

SITUATION Earnings and Revenue Quality work in a public acquirer facing HSR and sector regulators now turns on integration costs were sandbagged because a Phase II that found groundwater impact put regulatory-approval critical-path calendar in play. Working-capital true-up analyst should say what regulatory-approval critical-path calendar proves.

DECISION Working-capital true-up analyst in a public acquirer facing HSR and sector regulators must choose Proceed / Reprice / Walk / Hold using regulatory-approval critical-path calendar after a Phase II that found groundwater impact.

HYPOTHESES TO TEST 1. Working-capital true-up analyst can defend Proceed from regulatory-approval critical-path calendar after a Phase II that found groundwater impact in a M&A Due Diligence challenge. 2. Working-capital true-up analyst cannot defend Proceed from regulatory-approval critical-path calendar; Reprice is what the extract actually supports after a Phase II that found groundwater impact. 3. A Phase II that found groundwater impact never reached the population in regulatory-approval critical-path calendar — reopen intake, do not close integration costs were sandbagged. 4. Two facts in regulatory-approval critical-path calendar after a Phase II that found groundwater impact conflict for working-capital true-up analyst; hold this Earnings and Revenue Quality file.

ANALYSIS REQUIRED 1. Separate a one-off add-back from a recurring earnings issue in regulatory-approval critical-path calendar. 2. Map reps, earnout mechanics, and integration risk a public acquirer facing HSR and sector regulators would inherit. 3. Tie quality-of-earnings, working-capital, and contingent items in regulatory-approval critical-path calendar to integration costs were sandbagged. 4. For this M&A Due Diligence Earnings and Revenue Quality file, read regulatory-approval critical-path calendar against a Phase II that found groundwater impact and write the one fact that would move integration costs were sandbagged for working-capital true-up analyst.

RECOMMENDATION Choose Proceed / Reprice / Walk / Hold on this M&A Due Diligence / Earnings and Revenue Quality packet (regulatory-approval critical-path calendar after a Phase II that found groundwater impact). Lead with the M&A Due Diligence option regulatory-approval critical-path calendar can support after a Phase II that found groundwater impact, then the two facts that force it, then the Monday action for working-capital true-up analyst in a public acquirer facing HSR and sector regulators.

COMMAND RETURNS - Bottom-line M&A Due Diligence option on integration costs were sandbagged, then the evidence in regulatory-approval critical-path calendar, then the action for working-capital true-up analyst - Hypothesis scorecard against regulatory-approval critical-path calendar: supported / rejected / untestable - Regulatory or exam hook Earnings and Revenue Quality would cite - Earnings and Revenue Quality finding in regulatory-approval critical-path calendar that a second reviewer can re-perform